Soleus Capital Management’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ORGO
Soleus Capital Management's ORGO Position: Q3 2026 in Review
Soleus Capital Management increased its Organogenesis Holdings (ORGO) stake by 11% in Q3 2026, buying an estimated $2.28M and bringing the position to 11,300,951 shares worth $15.5M. The position accounts for 0.55% of the portfolio, ranked #45.
Soleus Capital Management first reported a position in ORGO in Q3 2021 and has held it in 21 quarters since. The position peaked at $53.9M in Q1 2025. 115 funds tracked by Wall St. Rank hold ORGO as of Q3 2026.
- Soleus Capital Management held 11,300,951 shares of Organogenesis Holdings worth $15.5M as of Q3 2026.
- Soleus Capital Management bought 1,160,000 Organogenesis Holdings shares in Q3 2026, an estimated $2.28M.
- Organogenesis Holdings made up 0.55% of Soleus Capital Management's portfolio in Q3 2026, its #45 holding.
- Soleus Capital Management first reported a position in Organogenesis Holdings in Q3 2021 and has held it in 21 quarters since.
- Soleus Capital Management's Organogenesis Holdings position peaked at $53.9M in Q1 2025.
- 115 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2026.
Based on Soleus Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.